Alphamab (Australia) Co Pty Ltd. clinical trials
A country office of Alphamab Oncology
The registry lists 2 studies whose lead sponsor is Alphamab (Australia) Co Pty Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 22, 2025.
Registry sponsor names on this page
- Alphamab (Australia) Co Pty Ltd.2 studies
Something wrong with this grouping? Tell us on the Alphamab Oncology page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Alphamab Oncology studies →
- First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant TumorsCompletedNCT05494918Phase 1
Sponsor listed in the registry: Alphamab (Australia) Co Pty Ltd.
- Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid TumorsStatus unknownNCT03529526Phase 1
Sponsor listed in the registry: Alphamab (Australia) Co Pty Ltd.